Article info
YIA 2017 moderated posters
9 Routine use of glycoprotein IIB/IIIA inhibitors is associated with improved survival in primary PCI
Citation
9 Routine use of glycoprotein IIB/IIIA inhibitors is associated with improved survival in primary PCI
Publication history
- First published November 27, 2017.
Online issue publication
November 27, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions